Literature DB >> 24135281

The role of Cdk5 in neuroendocrine thyroid cancer.

Karine Pozo1, Emely Castro-Rivera, Chunfeng Tan, Florian Plattner, Gert Schwach, Veronika Siegl, Douglas Meyer, Ailan Guo, Justin Gundara, Gabriel Mettlach, Edmond Richer, Jonathan A Guevara, Li Ning, Anjali Gupta, Guiyang Hao, Li-Huei Tsai, Xiankai Sun, Pietro Antich, Stanley Sidhu, Bruce G Robinson, Herbert Chen, Fiemu E Nwariaku, Roswitha Pfragner, James A Richardson, James A Bibb.   

Abstract

Medullary thyroid carcinoma (MTC) is a neuroendocrine cancer that originates from calcitonin-secreting parafollicular cells, or C cells. We found that Cdk5 and its cofactors p35 and p25 are highly expressed in human MTC and that Cdk5 activity promotes MTC proliferation. A conditional MTC mouse model was generated and corroborated the role of aberrant Cdk5 activation in MTC. C cell-specific overexpression of p25 caused rapid C cell hyperplasia leading to lethal MTC, which was arrested by repressing p25 overexpression. A comparative phosphoproteomic screen between proliferating and arrested MTC identified the retinoblastoma protein (Rb) as a crucial Cdk5 downstream target. Prevention of Rb phosphorylation at Ser807/Ser811 attenuated MTC proliferation. These findings implicate Cdk5 signaling via Rb as critical to MTC tumorigenesis and progression.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24135281      PMCID: PMC3849320          DOI: 10.1016/j.ccr.2013.08.027

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

Review 1.  RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease.

Authors:  Naoya Asai; Mayumi Jijiwa; Atsushi Enomoto; Kumi Kawai; Kengo Maeda; Masatoshi Ichiahara; Yoshiki Murakumo; Masahide Takahashi
Journal:  Pathol Int       Date:  2006-04       Impact factor: 2.534

2.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

Authors:  John Rush; Albrecht Moritz; Kimberly A Lee; Ailan Guo; Valerie L Goss; Erik J Spek; Hui Zhang; Xiang-Ming Zha; Roberto D Polakiewicz; Michael J Comb
Journal:  Nat Biotechnol       Date:  2004-12-12       Impact factor: 54.908

3.  Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.

Authors:  Georg Feldmann; Anjali Mishra; Seung-Mo Hong; Savita Bisht; Christopher J Strock; Douglas W Ball; Michael Goggins; Anirban Maitra; Barry D Nelkin
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 4.  Genetic alterations in thyroid cancer: the role of mouse models.

Authors:  K A B Knostman; S M Jhiang; C C Capen
Journal:  Vet Pathol       Date:  2007-01       Impact factor: 2.221

5.  High-resolution analysis of alterations in medullary thyroid carcinoma genomes.

Authors:  Karin Flicker; Peter Ulz; Harald Höger; Petra Zeitlhofer; Oskar A Haas; Annemarie Behmel; Wolfgang Buchinger; Christian Scheuba; Bruno Niederle; Roswitha Pfragner; Michael R Speicher
Journal:  Int J Cancer       Date:  2011-11-28       Impact factor: 7.396

Review 6.  The GDNF/RET signaling pathway and human diseases.

Authors:  M Takahashi
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

7.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Authors:  J A Bibb; G L Snyder; A Nishi; Z Yan; L Meijer; A A Fienberg; L H Tsai; Y T Kwon; J A Girault; A J Czernik; R L Huganir; H C Hemmings; A C Nairn; P Greengard
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Human medullary thyroid carcinoma in culture provides a model relating growth dynamics, endocrine cell differentiation, and tumor progression.

Authors:  C L Berger; A de Bustros; B A Roos; S S Leong; G Mendelsohn; M S Gesell; S B Baylin
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

9.  Cdk5 is essential for adult hippocampal neurogenesis.

Authors:  Diane C Lagace; David R Benavides; Janice W Kansy; Marina Mapelli; Paul Greengard; James A Bibb; Amelia J Eisch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

10.  Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.

Authors:  Nishant Agrawal; Yuchen Jiao; Mark Sausen; Rebecca Leary; Chetan Bettegowda; Nicholas J Roberts; Sheetal Bhan; Allen S Ho; Zubair Khan; Justin Bishop; William H Westra; Laura D Wood; Ralph H Hruban; Ralph P Tufano; Bruce Robinson; Henning Dralle; Sergio P A Toledo; Rodrigo A Toledo; Luc G T Morris; Ronald A Ghossein; James A Fagin; Timothy A Chan; Victor E Velculescu; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Barry D Nelkin; Douglas W Ball
Journal:  J Clin Endocrinol Metab       Date:  2012-12-21       Impact factor: 5.958

View more
  73 in total

1.  Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffold.

Authors:  S Zhang; M Ulrich; A Gromnicka; L Havlíček; V Kryštof; R Jorda; M Strnad; A M Vollmar; S Zahler
Journal:  Br J Pharmacol       Date:  2016-07-24       Impact factor: 8.739

2.  Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models.

Authors:  Chaoxin Hu; Tikva Dadon; Venugopal Chenna; Shinichi Yabuuchi; Rajat Bannerji; Robert Booher; Peter Strack; Nilofer Azad; Barry D Nelkin; Anirban Maitra
Journal:  Mol Cancer Ther       Date:  2015-04-30       Impact factor: 6.261

Review 3.  The history and future of targeting cyclin-dependent kinases in cancer therapy.

Authors:  Uzma Asghar; Agnieszka K Witkiewicz; Nicholas C Turner; Erik S Knudsen
Journal:  Nat Rev Drug Discov       Date:  2015-02       Impact factor: 84.694

4.  Cyclin-dependent Kinase 18 Promotes Oligodendrocyte Precursor Cell Differentiation through Activating the Extracellular Signal-Regulated Kinase Signaling Pathway.

Authors:  Yuchen Pan; Zeping Jiang; Dingya Sun; Zhenghao Li; Yingyan Pu; Dan Wang; Aijun Huang; Cheng He; Li Cao
Journal:  Neurosci Bull       Date:  2019-04-26       Impact factor: 5.203

Review 5.  Mouse models of thyroid cancer: A 2015 update.

Authors:  Lawrence S Kirschner; Zahida Qamri; Suresh Kari; Amruta Ashtekar
Journal:  Mol Cell Endocrinol       Date:  2015-06-27       Impact factor: 4.102

6.  Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma.

Authors:  Hai Song; Chuwen Lin; Erica Yao; Kuan Zhang; Xiaoling Li; Qingzhe Wu; Pao-Tien Chuang
Journal:  J Biol Chem       Date:  2017-01-24       Impact factor: 5.157

Review 7.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

8.  Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.

Authors:  Mohammad A Yousuf; Chunfeng Tan; Melissa I Torres-Altoro; Fang-Min Lu; Erik Plautz; Shanrong Zhang; Masaya Takahashi; Adan Hernandez; Steven G Kernie; Florian Plattner; James A Bibb
Journal:  J Neurochem       Date:  2016-05-25       Impact factor: 5.372

9.  Targeting the cyclin-dependent kinase 5 in metastatic melanoma.

Authors:  Samanta Sharma; Tian Zhang; Wojciech Michowski; Vito W Rebecca; Min Xiao; Roberta Ferretti; Jan M Suski; Roderick T Bronson; Joao A Paulo; Dennie Frederick; Anne Fassl; Genevieve M Boland; Yan Geng; Jacqueline A Lees; Rene H Medema; Meenhard Herlyn; Steven P Gygi; Piotr Sicinski
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-19       Impact factor: 11.205

10.  Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.

Authors:  Anisley Valenciaga; Elizabeth G Grubbs; Kyle Porter; Paul E Wakely; Michelle D Williams; Gilbert J Cote; Vasyl V Vasko; Motoyasu Saji; Matthew D Ringel
Journal:  Thyroid       Date:  2017-12       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.